scPharmaceuticals Inc. (SCPH) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts SCPH Hot Sheet
Join SI Premium – FREE
scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q2 EPS of ($0.44), $0.03 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $8.05 million versus the consensus estimate of $8.09 million.
For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Starbucks designates Val Bauduin as principal accounting officer
- M3-Brigade cancels shareholder meeting after terminating ReserveOne deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
